Gye Cheol Kwon
- Epidemiology
- Endocrinology, Diabetes and Metabolism top 10%
- Molecular Medicine top 5%
- Molecular Biology
- Cardiology and Cardiovascular Medicine
- Topics
- Antibiotic Resistance in Bacteria (8 papers)Diabetes, Cardiovascular Risks, and Lipoproteins (6 papers)Pharmaceutical and Antibiotic Environmental Impacts (6 papers)
- Partner nations
- South KoreaUnited States
In The Last Decade
Gye Cheol Kwon
46 papers receiving 685 citations
Hit Papers
Peers
Comparison fields: 5 of 99
- Epidemiology 218
- Endocrinology, Diabetes and Metabolism 181
- Molecular Medicine 140
- Molecular Biology 110
- Cardiology and Cardiovascular Medicine 89
Countries citing papers authored by Gye Cheol Kwon
This map shows the geographic impact of Gye Cheol Kwon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gye Cheol Kwon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gye Cheol Kwon more than expected).
Fields of papers citing papers by Gye Cheol Kwon
This network shows the impact of papers produced by Gye Cheol Kwon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gye Cheol Kwon. The network helps show where Gye Cheol Kwon may publish in the future.
Co-authorship network of co-authors of Gye Cheol Kwon
This figure shows the co-authorship network connecting the top 25 collaborators of Gye Cheol Kwon. A scholar is included among the top collaborators of Gye Cheol Kwon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gye Cheol Kwon. Gye Cheol Kwon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 1 | |
| 3 | 2 | |
| 4 | 16 | |
| 5 | 5 | |
| 6 | 2 | |
| 7 | 2 | |
| 8 | 1 | |
| 9 | 52 | |
| 10 | 1 | |
| 11 | Comparison of triglyceride glucose index, and related parameters to predict insulin resistance in Korean adults: An analysis of the 2007-2010 Korean National Health and Nutrition Examination Surveybreakdown → | 273 |
| 12 | 4 | |
| 13 | 3 | |
| 14 | 9 | |
| 15 | 2 | |
| 16 | 15 | |
| 17 | 3 | |
| 18 | 13 | |
| 19 | 43 | |
| 20 | 3 |
About Gye Cheol Kwon
Gye Cheol Kwon is a scholar working on Molecular Medicine, Endocrinology and Hematology, having authored 55 papers that have together received 693 indexed citations. Recurring topics across this work include Antibiotic Resistance in Bacteria (8 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (6 papers) and Pharmaceutical and Antibiotic Environmental Impacts (6 papers). The work is most often cited by research in Molecular Medicine (140 citations), Endocrinology (62 citations) and Endocrinology, Diabetes and Metabolism (181 citations). Gye Cheol Kwon has collaborated with scholars based in South Korea and United States. Frequent co-authors include Sun Hoe Koo, Jimyung Kim, Jinsook Lim, Yumi Park, Semi Kim, Seon Young Kim, Ji Youn Sung, Hyun‐Jin Kim, Sang Hoon Song and Young‐Chul Kim. Their work appears in journals such as PLoS ONE, Journal of Clinical Microbiology and Journal of Chromatography A.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.